Amylyx Pharmaceuticals, Inc.'s latest moves, explained simply — so you know why the numbers change.
Straight from SEC filings · updated 6 Aug 2026Annual meetings let shareholders decide on company leadership and major decisions affecting their investment.
Quarterly earnings show whether the company is making money and growing, which affects stock value.
Quarterly earnings show whether the company is making money and growing, which affects stock value.
Presentations help investors understand the company's strategy, products, and business plans.
Annual earnings show whether the company is profitable and successfully executing its business strategy.
Annual earnings show whether the company is profitable and successfully executing its business strategy.
Stocky reads Amylyx Pharmaceuticals, Inc.'s official filings with the U.S. Securities and Exchange Commission (SEC) — the 8-K, 10-Q and 10-K reports every public company must file — and summarizes each one in plain English, with a link back to the original document.
Amylyx Pharmaceuticals, Inc.'s most recent tracked filing was a 8-K on 4 Jun 2026: Stockholders vote at annual meeting on June 4.
No. These event summaries are educational — generated from public SEC filings to help beginners understand what a company is doing. They are not buy or sell recommendations.
Educational, not financial advice. Company events summarized from public SEC filings.
Data as of 6 Aug 2026.